Grant List
Represents Grant table in the DB
GET /v1/grants?page%5Bnumber%5D=1424&sort=principal_investigator
{ "links": { "first": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1&sort=principal_investigator", "last": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1442&sort=principal_investigator", "next": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1425&sort=principal_investigator", "prev": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1423&sort=principal_investigator" }, "data": [ { "type": "Grant", "id": "15876", "attributes": { "award_id": "1R21HL175588-01A1", "title": "Impact of SARS CoV2 on Human Herpesvirus Co-Infections", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Heart Lung and Blood Institute (NHLBI)" ], "program_reference_codes": [], "program_officials": [ { "id": 32514, "first_name": "EMMANUEL FRANCK", "last_name": "MONGODIN", "orcid": "", "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2025-09-01", "end_date": "2027-08-31", "award_amount": 234000, "principal_investigator": { "id": 44304, "first_name": "Rebecca L", "last_name": "Skalsky", "orcid": "", "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [], "awardee_organization": { "id": 2648, "ror": "", "name": "OREGON HEALTH & SCIENCE UNIVERSITY", "address": "", "city": "", "state": "OR", "zip": "", "country": "United States", "approved": true }, "abstract": "SARS-CoV2 infection has impacted millions of people worldwide. An estimated 5-10% of individuals continue to experience complex, long-term symptoms even after recovering from acute SARS-CoV2 infection. Long COVID has been linked to various risk factors, including the reactivation of persistent viral infections like Epstein-Barr virus (EBV) and other human herpesviruses. Understanding the timing of persistent virus reactivation is an important step in devising effective mitigation strategies. Moreover, causal relationships between herpesvirus reactivation and long COVID remain unclear. Current diagnostic tools are insufficient and there remains an unmet need for early predictive and prognostic biomarkers. Notably, human herpesviruses such as EBV express numerous viral microRNAs throughout infection and SARS-CoV2 itself encodes a miRNA-like small noncoding RNA. Additionally, SARS-CoV2 infection dramatically disrupts the host miRNA environment. Given that miRNAs are highly stable in circulation and have demonstrated utility as biomarkers for various clinical conditions, we hypothesize that herpesvirus-encoded miRNAs could serve as diagnostic and/or prognostic indicators of SARS- CoV2-related illnesses. Our preliminary studies on SARS-CoV2 cases uncovered an increased prevalence of circulating EBV miRNAs in symptomatic individuals. In this project, we will evaluate circulating viral and host miRNA signatures in SARS-CoV2 infections. Outcomes of these analyses will shed light on miRNAs that can be used as systemic biomarkers to aid in stratifying patients and identifying those with active herpesvirus infections.", "keywords": [ "2019-nCoV", "Acute", "Address", "Age", "Autoimmunity", "Biological Markers", "Blood", "Blood specimen", "Body Fluids", "COVID-19", "COVID-19 pathogenesis", "COVID-19 patient", "COVID-19 severity", "Cells", "Cessation of life", "Chronic", "Chronic Obstructive Pulmonary Disease", "Circulation", "Clinical", "Complex", "Cross-Sectional Studies", "Cytomegalovirus", "Data", "Data Set", "Development", "Diagnostic", "Disease", "Environment", "Eukaryota", "Gene Expression", "Geographic Locations", "Herpesviridae", "Herpesviridae Infections", "Herpesvirus 1", "Human", "Human Herpesvirus 4", "Immune", "Individual", "Infection", "Investigation", "Link", "Long COVID", "Meta-Analysis", "Methods", "MicroRNAs", "Nature", "Outcome", "Patients", "Peripheral Blood Mononuclear Cell", "Persons", "Plasma", "Post-Acute Sequelae of SARS-CoV-2 Infection", "Prevalence", "Prognostic Marker", "Property", "Publishing", "Quality Control", "RNA", "Reporting", "Respiratory Disease", "Risk Factors", "SARS-CoV-2 infection", "Sampling", "Serum", "Signaling Molecule", "Small RNA", "Symptoms", "Tuberculosis", "Untranslated RNA", "Vaccination", "Viral", "Virus", "Virus Diseases", "Whole Blood", "acute COVID-19", "analytical method", "co-infection", "comorbidity", "diagnostic tool", "differential expression", "early detection biomarkers", "experience", "extracellular", "high risk", "latent infection", "miRNA expression profiling", "molecular marker", "novel therapeutics", "patient stratification", "posttranscriptional", "predictive marker", "sex", "symptomatic COVID-19", "transcriptome" ], "approved": true } }, { "type": "Grant", "id": "15877", "attributes": { "award_id": "1F31DA063126-01", "title": "A statewide examination of the address-level relationships between residential eviction proceedings and overdose events in Rhode Island", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute on Drug Abuse (NIDA)" ], "program_reference_codes": [], "program_officials": [ { "id": 44305, "first_name": "ERIN MARGARET", "last_name": "PARKER", "orcid": "", "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2025-09-01", "end_date": "2027-08-31", "award_amount": 49538, "principal_investigator": { "id": 44306, "first_name": "Alexandra", "last_name": "Skinner", "orcid": "", "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [], "awardee_organization": { "id": 3365, "ror": "", "name": "BROWN UNIVERSITY", "address": "", "city": "", "state": "RI", "zip": "", "country": "United States", "approved": true }, "abstract": "PROPOSAL SUMMARY In the wake of the COVID-19 pandemic, overdose mortality and affordable housing shortages have reached unprecedented levels in Rhode Island and across the United States. Housing insecurity is a known risk factor for overdose, yet the effects of residential eviction—a structural and policy-sensitive cause of housing insecurity—on overdose risks are understudied. Eviction is a complex legal process composed of a series of stages, each of which may impact overdose risk and thus offers opportunity for public health intervention. The objective of this proposal is to pursue a thorough examination of the relationship between residential eviction proceedings (i.e., filing, hearing, and enforcement) and overdose at the address level in Rhode Island, to better inform eviction prevention policies that complement ongoing harm reduction and overdose prevention efforts. The proposed research will leverage the wealth of centralized, high-resolution data available in Rhode Island—and our team’s established relationship with the state health department—to construct a longitudinal dataset with data linked from several administrative sources. We will first characterize the prevalence and time course of eviction proceedings relative to non-fatal or fatal overdose events by conducting sequence and cluster analyses to operationalize variation in the order, duration, and timing of eviction proceedings before and after a given overdose event (AIM 1). We will then estimate the address-level causal effect of residential eviction proceedings on risk of non-fatal and fatal overdose, both overall and by race and ethnicity of overdose decedents, using a sequential target trial approach (AIM 2). The proposed research will be among the first of its kind to link eviction records with address-level health data to characterize heterogeneity in the duration and timing of eviction proceedings, to examine a causal link between eviction and overdose, and to explore differential impacts of eviction on overdose death by race and ethnicity. Because eviction is an intervenable mechanism of housing vulnerability that may be associated with overdose risk, findings from this work may elucidate novel avenues for addressing the intersecting housing and overdose crises in tandem. The proposed research will be completed by the principal investigator with support and mentorship from collaborators with substantial expertise in advanced quantitative methods for life course epidemiology and causal inference. The training activities detailed in this application, focused on advancing skills in epidemiologic study design and longitudinal data analysis and developing a deep contextual knowledge of the social and legal implications of eviction proceedings, will prepare the principal investigator for a career as an independent social epidemiologist and academic researcher.", "keywords": [ "Acute", "Address", "Alaska Native population", "American Indian Population", "Applied Skills", "Black race", "COVID-19 pandemic", "Censuses", "Characteristics", "Cluster Analysis", "Complement", "Complex", "County", "Data", "Data Analyses", "Data Linkages", "Data Set", "Discrimination", "Dose", "Drug user", "Economics", "Epidemiologist", "Epidemiology", "Ethnic Origin", "Event", "Exposure to", "Funding", "Goals", "Harm Reduction", "Health", "Hearing", "Heterogeneity", "Hispanic", "Housing", "Individual", "Intervention", "Knowledge", "Learning", "Legal", "Life Cycle Stages", "Life course epidemiology", "Link", "Mentorship", "Methodology", "Methods", "Neighborhoods", "Overdose", "Patients", "Policies", "Prevalence", "Prevention", "Principal Investigator", "Process", "Race", "Records", "Research", "Research Design", "Research Personnel", "Resolution", "Rhode Island", "Risk", "Risk Factors", "Sequence Analysis", "Series", "Shapes", "Source", "Structural Models", "Time", "Training", "Training Activity", "United States", "United States National Institutes of Health", "Variant", "Work", "career", "data management", "epidemiology study", "health data", "housing insecurity", "legal implication", "longitudinal dataset", "marginalized community", "mortality", "neglect", "novel", "overdose death", "overdose prevention", "overdose risk", "psychosocial", "public health intervention", "residence", "response", "risk prediction", "segregation", "skills", "social", "social implication", "stressor", "structural health determinants" ], "approved": true } }, { "type": "Grant", "id": "16179", "attributes": { "award_id": "5F31DA063126-02", "title": "A statewide examination of the address-level relationships between residential eviction proceedings and overdose events in Rhode Island", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute on Drug Abuse (NIDA)" ], "program_reference_codes": [], "program_officials": [ { "id": 44305, "first_name": "ERIN MARGARET", "last_name": "PARKER", "orcid": "", "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2025-09-01", "end_date": "2027-08-31", "award_amount": 50114, "principal_investigator": { "id": 44306, "first_name": "Alexandra", "last_name": "Skinner", "orcid": "", "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [], "awardee_organization": { "id": 3365, "ror": "", "name": "BROWN UNIVERSITY", "address": "", "city": "", "state": "RI", "zip": "", "country": "United States", "approved": true }, "abstract": "PROPOSAL SUMMARY In the wake of the COVID-19 pandemic, overdose mortality and affordable housing shortages have reached unprecedented levels in Rhode Island and across the United States. Housing insecurity is a known risk factor for overdose, yet the effects of residential eviction—a structural and policy-sensitive cause of housing insecurity—on overdose risks are understudied. Eviction is a complex legal process composed of a series of stages, each of which may impact overdose risk and thus offers opportunity for public health intervention. The objective of this proposal is to pursue a thorough examination of the relationship between residential eviction proceedings (i.e., filing, hearing, and enforcement) and overdose at the address level in Rhode Island, to better inform eviction prevention policies that complement ongoing harm reduction and overdose prevention efforts. The proposed research will leverage the wealth of centralized, high-resolution data available in Rhode Island—and our team’s established relationship with the state health department—to construct a longitudinal dataset with data linked from several administrative sources. We will first characterize the prevalence and time course of eviction proceedings relative to non-fatal or fatal overdose events by conducting sequence and cluster analyses to operationalize variation in the order, duration, and timing of eviction proceedings before and after a given overdose event (AIM 1). We will then estimate the address-level causal effect of residential eviction proceedings on risk of non-fatal and fatal overdose, both overall and by race and ethnicity of overdose decedents, using a sequential target trial approach (AIM 2). The proposed research will be among the first of its kind to link eviction records with address-level health data to characterize heterogeneity in the duration and timing of eviction proceedings, to examine a causal link between eviction and overdose, and to explore differential impacts of eviction on overdose death by race and ethnicity. Because eviction is an intervenable mechanism of housing vulnerability that may be associated with overdose risk, findings from this work may elucidate novel avenues for addressing the intersecting housing and overdose crises in tandem. The proposed research will be completed by the principal investigator with support and mentorship from collaborators with substantial expertise in advanced quantitative methods for life course epidemiology and causal inference. The training activities detailed in this application, focused on advancing skills in epidemiologic study design and longitudinal data analysis and developing a deep contextual knowledge of the social and legal implications of eviction proceedings, will prepare the principal investigator for a career as an independent social epidemiologist and academic researcher.", "keywords": [ "Acute", "Address", "Alaska Native population", "American Indian Population", "Applied Skills", "Black race", "COVID-19 pandemic", "Censuses", "Characteristics", "Cluster Analysis", "Complement", "Complex", "County", "Data", "Data Linkages", "Data Set", "Discrimination", "Dose", "Drug user", "Economics", "Epidemiologic Research Design", "Epidemiologist", "Ethnic Origin", "Event", "Exposure to", "Funding", "Goals", "Harm Reduction", "Health", "Hearing", "Heterogeneity", "Hispanic", "Housing", "Individual", "Intervention", "Knowledge", "Learning", "Legal", "Life course epidemiology", "Link", "Mentorship", "Methodology", "Methods", "Neighborhoods", "Overdose", "Patients", "Policies", "Prevalence", "Prevention", "Principal Investigator", "Process", "Race", "Records", "Research", "Research Personnel", "Rhode Island", "Risk", "Risk Factors", "Sequence Analysis", "Series", "Shapes", "Source", "Structural Models", "Time", "Training", "Training Activity", "United States", "United States National Institutes of Health", "Variant", "Work", "career", "causal inference", "chronic exposures", "data management", "epidemiology training", "health data", "high-resolution", "housing insecurity", "legal implication", "life course", "longitudinal analysis", "longitudinal dataset", "longitudinal research", "marginalized community", "mortality", "neglect", "novel", "overdose death", "overdose prevention", "overdose risk", "psychosocial", "public health intervention", "residence", "response", "risk prediction", "segregation", "skills", "social", "social implication", "stressor", "structural health determinants" ], "approved": true } }, { "type": "Grant", "id": "15878", "attributes": { "award_id": "1R01AI189484-01", "title": "Role of norovirus capsid dynamics in adaptive immune evasion", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Allergy and Infectious Diseases (NIAID)" ], "program_reference_codes": [], "program_officials": [ { "id": 44307, "first_name": "RODOLFO M", "last_name": "ALARCON", "orcid": "", "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2025-09-01", "end_date": "2029-08-31", "award_amount": 2920356, "principal_investigator": { "id": 44308, "first_name": "THOMAS JAMES.", "last_name": "SMITH", "orcid": "", "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [ { "id": 44309, "first_name": "Christiane", "last_name": "Wobus", "orcid": "", "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "awardee_organization": { "id": 851, "ror": "", "name": "UNIVERSITY OF TEXAS MED BR GALVESTON", "address": "", "city": "", "state": "TX", "zip": "", "country": "United States", "approved": true }, "abstract": "Human noroviruses are responsible for almost a fifth of all cases of gastroenteritis worldwide. Containment of disease is difficult since as few as ten virions are sufficient to infect a normal adult. Noroviruses evolve continuously with new strains arising every 2-4 years that cause worldwide epidemics. Emergence of new strains can increase the number of cases by 50%. In the US alone, there are more than 2 million outpatient clinic visits, ~100,000 hospitalizations, and ~900 deaths (mostly among adults 65 and older) annually. Globally, there are ~200 million cases among children less than 5 years old, leading to ~50,000 deaths every year. However, no vaccines or antivirals are approved to limit infections. Efforts to develop an effective vaccine have been hindered by a lack of detailed structural information about antibody binding and the mechanisms of antibody escape. Understanding these processes has been difficult with human noroviruses because of the lack of a tissue culture system that supports the generation of a cell culture-derived virus stock and small animal model. To this end, we will be using the highly tractable mouse norovirus system where we have a highly efficient cell culture system, infectious clone, and natural mouse model. We have recently shown, for the first-time, that a virus (i.e., mouse norovirus, MNV) can use host metabolites to switch between two ‘faces’: one recognized by antibodies from recovered animals (apo) and one activated for infection. In conditions found in systemic circulation, the protruding domain (P domain) of the apo form floats above the shell by ~16Å and the loops at the tip are splayed apart. It is this conformation to which the antibody response is made. Once the virus enters the alimentary canal, low pH, bile salts, and metal ions individually and synergistically activate the virus whereby the P domain rotates and contracts onto the shell, and the antibody binding epitope at the tip of the P domain closes. This blocks antibody recognition while enhancing receptor binding. Essentially, each time MNV infects the host, the antibody response is naïve for that conformation. Importantly, we propose that this could explain why the antibody response to norovirus infection in both mice and humans appears to be notoriously short-lived. The goal of this proposal is to test our immune evasion model by creating mutant forms of MNV locked into either the apo or activated states and observing how those changes affect the pathogenesis and immune response in the host. These studies will detail the activation process at the molecular level, elucidate the reason why caliciviruses evolved such mobile P domains, and greatly impact the development of norovirus vaccines and therapeutics. Finally, subsequent to our publications, similar host metabolite immune evasion was observed with COVID-19. Therefore, our results will increase awareness of possible similar features in other virus families and may become paradigms in the future.", "keywords": [ "2019-nCoV", "5 year old", "Acute", "Adult", "Affect", "Affinity", "Ambulatory Care Facilities", "Animal Model", "Animals", "Annual Reports", "Anti-viral Agents", "Antibodies", "Antibody Affinity", "Antibody Response", "Awareness", "Bile Acids", "Binding", "Biology", "Blocking Antibodies", "C-terminal", "COVID-19", "Calicivirus", "Capsid", "Capsid Proteins", "Case Study", "Cell Culture System", "Cell Culture Techniques", "Cessation of life", "Characteristics", "Child", "Circulation", "Clinic Visits", "Containment", "Contracts", "Cryoelectron Microscopy", "Crystallography", "Development", "Dimerization", "Disease", "Distal", "Dose", "Environment", "Epidemic", "Epitopes", "Exhibits", "Face", "Failure", "Family", "Future", "Gastroenteritis", "Gastrointestinal tract structure", "Generations", "Genetic Variation", "Genome", "Goals", "Hospitalization", "Human", "Immune", "Immune Evasion", "Immune response", "Immunity", "Immunologic Memory", "Immunologics", "In Vitro", "Individual", "Infection", "Ingestion", "Innate Immune Response", "Intestines", "Invaded", "Ions", "Libraries", "Ligands", "Lymphatic System", "Mediating", "Metals", "Modeling", "Molecular", "Molecular Conformation", "Mus", "Mutagenesis", "Norovirus", "Pathogenesis", "Pathogenicity", "Persons", "Population", "Process", "Property", "Publications", "Retinal blind spot", "Role", "Rotation", "Series", "Site", "Spleen", "Structure", "Support System", "Surface", "Symptoms", "System", "Tertiary Protein Structure", "Testing", "Therapeutic", "Time", "Tissues", "Vaccines", "Viral Pathogenesis", "Virion", "Virus", "Viviparous-1 protein", "Work", "acute infection", "adaptive immune response", "adaptive immunity", "bile salts", "biophysical techniques", "design", "gastrointestinal epithelium", "human old age (65+)", "improved", "in vivo", "in vivo evaluation", "mouse model", "mutant", "oral infection", "receptor", "receptor binding", "recombinant virus", "reverse genetics", "structural biology", "tissue culture", "tool", "vaccine development", "viral RNA", "volunteer" ], "approved": true } }, { "type": "Grant", "id": "15879", "attributes": { "award_id": "1R01HD120113-01", "title": "DISSECTING MECHANISMS OF INFLAMMATORY SIGNALING ACROSS THE MATERNAL FETAL INTERFACE", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" ], "program_reference_codes": [], "program_officials": [ { "id": 44310, "first_name": "DENISE", "last_name": "RUSSO", "orcid": "", "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2025-09-15", "end_date": "2028-05-31", "award_amount": 2255352, "principal_investigator": { "id": 44311, "first_name": "Christiana Elizabeth", "last_name": "Smith-Anderson", "orcid": "", "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [], "awardee_organization": { "id": 3385, "ror": "", "name": "UNIVERSITY OF COLORADO DENVER", "address": "", "city": "", "state": "CO", "zip": "", "country": "United States", "approved": true }, "abstract": "Infants exposed in utero to maternal inflammatory disorders are at risk of long-lasting health impacts, such as altered neurodevelopmental outcomes or dysregulated immune responses. When maternal infections are the inflammatory stimulus, these adverse neonatal outcomes can occur in the absence of congenital infection. Our preliminary data show that infants who are HIV-exposed, but uninfected experience high rates of morbidity and mortality that are associated with maternal inflammation in a dose-dependent fashion. Early reports suggest that acute maternal infection with COVID-19 can have profound impacts on fetal immune development. Inflammatory signaling across the maternal-fetal interface during a critical fetal developmental window is likely to be responsible for these adverse neonatal outcomes. However, critical gaps exist in our understanding of how inflammatory signals are transferred across the placenta. The overarching goal of this proposal is to determine the cellular and molecular mechanisms involved in the transfer of inflammatory signals across the maternal-fetal interface in the setting of acute or chronic viral infection. We will capitalize upon access to samples from pregnancies complicated by either HIV, which results in chronic inflammation, or SARS-CoV-2, which causes severe acute inflammation, to address the following Specific Aims: 1) to profile the transcriptomic signatures of heterogenous maternal and fetal cell types in their in situ environment within placentas from pregnancies affected by HIV or SARS-CoV-2 versus healthy pregnancies; 2) to compare concentrations of inflammatory and regulatory biomarkers in maternal and infant peripheral blood, cord blood and placentas from term pregnancies affected by HIV or SARS-CoV-2 versus healthy pregnancies and determine their association with placental gene expression; and 3) to characterize inflammatory signaling across the maternal-fetal interface using a 3- dimensional in vitro model that incorporates key placental cell types. This proposal includes several innovative components, including the use of advanced bioinformatics to directly correlate placental gene expression data from a single-cell spatial transcriptomics assay to the peripheral concentrations of inflammatory biomarkers within the same participants, and the development of a novel Transwell-based model of the human placenta that can be used to mechanistically interrogate the role of each cell type in the transfer or inflammatory signals. Disentangling the mechanisms responsible for the transfer of inflammation across the maternal-fetal interface will ultimately allow for the identification of therapeutic agents to modulate inflammation in pregnancy, thereby preventing adverse neurodevelopmental and/or immunologic consequences to the fetus.", "keywords": [ "2019-nCoV", "3-Dimensional", "Acute", "Address", "Affect", "Amniotic Fluid", "Animals", "Architecture", "Bioinformatics", "Biological Assay", "Biological Markers", "COVID-19", "COVID-19 diagnosis", "Cells", "Chronic", "Circulation", "Coculture Techniques", "Data", "Decidua", "Decidual Cell Reactions", "Development", "Disease", "Dose", "Endometrial Stromal Cell", "Endothelial Cells", "Environment", "Equilibrium", "Exposure to", "Fetal Growth Retardation", "Fetal Tissues", "Fetus", "Fibroblasts", "Future", "Gene Expression", "Geography", "Goals", "HIV", "HIV-exposed uninfected infant", "HIV/HBV", "Health", "Human", "Hypertension", "Immune", "Immune response", "Immunologics", "Impairment", "In Situ", "Infant", "Infant Health", "Infection", "Inflammation", "Inflammatory", "Innate Immune Response", "Insulin-Dependent Diabetes Mellitus", "Interleukin-1 alpha", "Interleukin-6", "Leukocytes", "Macrophage", "Malaria", "Maternal-Fetal Exchange", "Measures", "Mediator", "Mesenchymal Stem Cells", "Modeling", "Molecular", "Morbidity - disease rate", "Mothers", "Neonatal", "Obesity", "Outcome", "Participant", "Pathway interactions", "Peripheral", "Placenta", "Plasma", "Pregnancy", "Pregnancy Complications", "Pregnant Women", "Premature Labor", "Proteomics", "Reporting", "Respiratory Tract Infections", "Risk", "Role", "Sampling", "Second Pregnancy Trimester", "Signal Transduction", "Source", "Spontaneous abortion", "Stimulus", "TNF gene", "Testing", "Therapeutic Agents", "Tissues", "Umbilical Cord Blood", "Umbilical vein", "Villous", "Virus Diseases", "adverse pregnancy outcome", "cell type", "chemokine", "congenital infection", "cytokine", "differential expression", "ex vivo perfusion", "experience", "fetal", "fetus cell", "healthy pregnancy", "human-based research", "immunoregulation", "in vitro Model", "in vivo", "inflammatory milieu", "innovation", "maternal inflammation", "mortality", "neonatal outcome", "novel", "offspring", "peripheral blood", "pregnant", "prenatal exposure", "prevent", "spatial transcriptomics", "transcriptomics", "trophoblast" ], "approved": true } }, { "type": "Grant", "id": "15880", "attributes": { "award_id": "1R21HL175534-01A1", "title": "A novel shift-level approach to optimizing ICU interprofessional team composition for mechanically ventilated adults", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Heart Lung and Blood Institute (NHLBI)" ], "program_reference_codes": [], "program_officials": [ { "id": 44231, "first_name": "INGRID CECILIA", "last_name": "ESPINOZA GRANDON", "orcid": "", "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2025-09-01", "end_date": "2027-08-31", "award_amount": 272226, "principal_investigator": { "id": 44312, "first_name": "Deena Kelly", "last_name": "Costa", "orcid": "", "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [ { "id": 44313, "first_name": "Amy Witkoski", "last_name": "Stimpfel", "orcid": "", "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "awardee_organization": { "id": 3390, "ror": "", "name": "NEW YORK UNIVERSITY", "address": "", "city": "", "state": "NY", "zip": "", "country": "United States", "approved": true }, "abstract": "At the core of critical care delivery is the interprofessional team, comprised of nurses, physicians, and respiratory therapists, who provide around-the-clock care to the most critically ill patients. The COVID-19 pandemic underscored the need for a robust critical care workforce and exposed existing structural inequities in the healthcare system. Research has shown disparities in mechanical ventilation (MV) care and outcomes based on patient characteristics, such as age and ethnicity. One evidence-based practice associated with improved outcomes for MV patients—spontaneous awakening and spontaneous breathing trials (SATs and SBTs)—requires effective coordination and collaboration among the entire team. For decades, researchers have sought to optimize the organization of critical care teams to enhance patient outcomes. While studies within individual professions, such as nurses or physicians, have examined the impact of clinician characteristics (e.g., experience) and scheduling characteristics (e.g., overtime) on outcomes, there remains a dearth of research investigating how variations in clinician and scheduling characteristics across the entire team influences patient outcomes. To address this knowledge gap, this application aims to determine how clinician and scheduling characteristics impact patient outcomes, and explore the moderating effect that clusters of patient characteristics have on the relationship between clinician and scheduling characteristics on patient outcomes. We propose a novel secondary analysis utilizing a unique dataset that links electronic health record data from nearly 17,000 critically ill patients to human resource clinician characteristics of 8,000 clinicians across 5 intensive care units from 2018-2021. Our specific aims are: 1) Test the hypothesis that patients cared for by teams with better clinician characteristics and scheduling characteristics will be more likely to receive SATs and SBTs each shift (when eligible), more likely to be extubated each shift, and less likely to die each shift. Among (n=8,952) MV patients, we will use a patient-level design and a longitudinal, repeat-measures analysis, where patients serve as their own control. 2) Evaluate the moderating effect of patient characteristics on the relationship between clinician and scheduling characteristics and patient outcomes. Among all ICU patients (N=16,940), we will use multiple interactions to identify what clusters of patient characteristics (e.g., age, sex, race, ethnicity) may be most vulnerable, i.e., experience negative outcomes, to variation in clinician and scheduling characteristics of the assigned team. If supported by our findings and replicated in a larger national study, then a patient-centered approach to ICU team assignments could be a cost-effective intervention that does not require additional staffing. This proposal has the potential to significantly transform the way interprofessional teams are assigned to ICU patients.", "keywords": [ "Address", "Admission activity", "Adult", "Age", "American", "Analgesics", "Attention", "Breathing", "COVID-19 pandemic", "Caring", "Characteristics", "Chest", "Collaborations", "Complex", "Coordination and Collaboration", "Critical Care", "Critical Illness", "Data", "Data Analyses", "Data Set", "Disparity", "Education", "Electronic Health Record", "Eligibility Determination", "Ensure", "Equity", "Ethnic Origin", "Evidence based practice", "Goals", "Health Care Systems", "Health Professional", "Hospitals", "Human Resources", "Individual", "Inequity", "Intensive Care Units", "Interruption", "Knowledge", "Life", "Link", "Measures", "Mechanical ventilation", "Morbidity - disease rate", "National Heart Lung and Blood Institute", "Nurse Practitioners", "Nurses", "Nursing Societies", "Outcome", "Patient Care", "Patient Care Team", "Patient-Focused Outcomes", "Patients", "Pattern", "Physician Assistants", "Physicians", "Positioning Attribute", "Provider", "Race", "Readiness", "Research", "Research Personnel", "Research Project Grants", "Schedule", "Sedation procedure", "Students", "Survival Rate", "System", "Team Nursing", "Testing", "Variant", "Work", "care delivery", "clinical practice", "cost", "cost effective intervention", "design", "disparity reduction", "evidence base", "experience", "health inequalities", "implementation barriers", "improved", "improved outcome", "innovation", "meetings", "member", "mortality", "novel", "patient oriented", "respiratory", "secondary analysis", "sex" ], "approved": true } }, { "type": "Grant", "id": "15881", "attributes": { "award_id": "1K99AI190056-01", "title": "Regulation and Function of respiratory mucosal immunity post SARS-CoV-2 vaccination and infection", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Allergy and Infectious Diseases (NIAID)" ], "program_reference_codes": [], "program_officials": [ { "id": 32599, "first_name": "MICHELLE MARIE", "last_name": "ARNOLD", "orcid": "", "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2025-09-03", "end_date": "2027-08-31", "award_amount": 108273, "principal_investigator": { "id": 44314, "first_name": "Jinyi", "last_name": "Tang", "orcid": "", "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [], "awardee_organization": { "id": 3391, "ror": "", "name": "UNIVERSITY OF VIRGINIA", "address": "", "city": "", "state": "VA", "zip": "", "country": "United States", "approved": true }, "abstract": "Current intramuscular COVID-19 vaccines, despite eliciting robust systemic immune responses, generate suboptimal neutralizing antibody (nAb), IgA Ab, and cellular responses in the respiratory mucosal. This is likely why current vaccines are less effective at preventing infection and transmission. The role of mucosal immunity in protecting against respiratory viral infection remains largely unexplored. The long-term goal of this research is to comprehensively understand the differentiation, function, regulation, and interaction of respiratory immune cells. Pilot data revealed that people with hybrid immunity from SARS-CoV-2 infection and vaccination exhibit significantly high levels of antigen-specific IgA and nAbs in the respiratory mucosa, compared to those who got vaccinated or infected alone. Further, recent research and our initial findings suggest that mucosal IgA is locally produced by lung-resident B cells during both primary infection and reinfection, yet the specific role and development of mucosal IgA are not fully understood. Therefore, the overall objectives of this application are to a) understand systemic and mucosal immunity in people with hybrid immunity, b) define immune compartments that confer protection and transmission in animal models, and c) unravel the mechanisms underlying the respiratory protection of mucosal immunity. The central hypothesis is that respiratory IgA provides neutralization and protection against heterologous infection, facilitated by an orchestrated interaction between macrophages, CD4 Th1 cells, and IgA+ B cells in the respiratory mucosa. This hypothesis will be tested by pursuing three specific aims: 1) To identify the respiratory mucosal immunity in people with hybrid immunity, 2) To study protection and transmission following SARS-CoV-2 breakthrough infection or mucosal vaccine booster in animal models primed with mRNA vaccines, and 3) To elucidate the mechanisms underlying the mucosal protection of respiratory immunity. Aim 1 will systematically profile the immune signatures in the blood, nasal cavity, and lower airway in children with hybrid immunity. Aim 2 will utilize mouse and hamster models of hybrid immunity and mucosal vaccine booster to study protection and transmission. Under Aim 3, we will investigate the mechanism of mucosal protection in both humans and mice. This research will advance our understanding of respiratory immunology and vaccinology, potentially impacting the global fight against SARS-CoV-2 and future respiratory viruses. This project will provide the applicant, Dr. Jinyi Tang, with experimental and conceptual training to develop his research program and ensure his transition to an independent tenure- track position. Dr. Tang will be mentored by a committee of experienced immunologist, virologist and clinician-scientist specializing in mucosal viral immunology, led by primary mentor Dr. Jie Sun. The planned career development activities will ensure Dr. Tang achieves his long-term goals of consistent manuscript publishing, achieving independent funding, and training of the next generation of scientists.", "keywords": [ "2019-nCoV", "Address", "Animal Model", "Antibody Formation", "Antibody Response", "Antibody-mediated protection", "Antigens", "B-Lymphocytes", "Blood", "Bronchoscopy", "CD4 Positive T Lymphocytes", "COVID-19 pandemic", "COVID-19 vaccination", "COVID-19 vaccine", "Cells", "Cellular Immunity", "Cessation of life", "Child", "Circulation", "Coculture Techniques", "Communicable Diseases", "Data", "Development", "Disease", "Ensure", "Exhibits", "Funding", "Future", "Generations", "Genetic", "Goals", "Hamsters", "Human", "Hybrids", "Immune", "Immune Evasion", "Immune response", "Immunity", "Immunoglobulin A", "Immunologist", "Immunology", "In Vitro", "Infection", "Infection prevention", "Innate Immune Response", "Intramuscular", "Knowledge", "Lung", "Macrophage", "Manuscripts", "Memory B-Lymphocyte", "Mentors", "Methods", "Modeling", "Morbidity - disease rate", "Mucosal Immunity", "Mucous Membrane", "Mus", "Nasal cavity", "Outcome", "Pediatric cohort", "Persons", "Plasma Cells", "Play", "Positioning Attribute", "Preventive measure", "Primary Infection", "Production", "Public Health", "Publishing", "RNA vaccine", "Regulation", "Research", "Respiratory Mucosa", "Respiratory Tract Infections", "Respiratory physiology", "Role", "SARS-CoV-2 immunity", "SARS-CoV-2 infection", "SARS-CoV-2 variant", "Scientist", "T-Lymphocyte", "Testing", "Th1 Cells", "Training", "Transforming Growth Factor beta", "Vaccinated", "Vaccination", "Vaccinee", "Vaccines", "Variant", "Viral", "Viral Respiratory Tract Infection", "Viral Vector", "Work", "adaptive immune response", "booster vaccine", "breakthrough infection", "career", "career development", "cross reactivity", "cytokine", "design", "experience", "fighting", "high dimensionality", "human model", "improved", "in vivo", "insight", "interleukin-21", "mortality", "mouse model", "mucosal vaccine", "multiple omics", "neutralizing antibody", "next generation", "novel", "novel vaccines", "pathogen", "prevent", "programs", "respiratory", "respiratory virus", "response", "tenure track", "transmission process", "vaccine-induced immunity", "vaccinology", "variants of concern" ], "approved": true } }, { "type": "Grant", "id": "15882", "attributes": { "award_id": "1K99AI194972-01", "title": "The Role of Tunneling Nanotubes and Mitochondrial programming in HIV-Associated Placental Dysfunction", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Allergy and Infectious Diseases (NIAID)" ], "program_reference_codes": [], "program_officials": [ { "id": 44315, "first_name": "UDAY K", "last_name": "SHANKAR", "orcid": "", "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2025-09-01", "end_date": "2027-08-31", "award_amount": 156744, "principal_investigator": { "id": 44316, "first_name": "Rafael", "last_name": "Tomoya Michita", "orcid": "", "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [], "awardee_organization": { "id": 2610, "ror": "", "name": "BAYLOR COLLEGE OF MEDICINE", "address": "", "city": "", "state": "TX", "zip": "", "country": "United States", "approved": true }, "abstract": "/ ABSTRACT HIV is known to be transmissible from mother to the developing fetus during pregnancy, leading to adverse health outcomes for both. Although HIV is linked to placental pathologies, there is still a large gap in knowledge about the mechanisms underlying HIV-associated pregnancy complications, despite four decades of research in general on HIV topics. The objective of this project is to investigate the role of intercellular conduits composed of F-actin microtubules that connect plasma membranes of neighboring cells enabling cytoplasmic continuing and intercellular transfer of cargo. These conduits are known as tunneling nanotubes (TNTs). Recent investigations by the PI and others have demonstrated that other viruses such as Zika and SARS-CoV-2 induce the formation of TNTs in placental trophoblast cells, and there is evidence they serve as a means of mitochondrial transfer and possibly viral transfer that promotes infectious spread. There is evidence that HIV induces TNT formation in neurons, but it is not known whether the virus has this effect on placental cells. Building on prior studies and ongoing work by the PI, the central hypothesis of this project is that HIV uses TNTs to spread infection in trophoblasts, and that TNTs mediate placental dysfunction by transferring damaged mitochondria and adversely reprogramming trophoblast metabolism. This metabolic reprogramming may contribute to placental dysfunction and adverse pregnancy outcomes. Aim 1 of this project will elucidate the molecular mechanisms of TNT formation between HIV-infected immune cells and trophoblasts. Aim 2 will determine the impact of HIV on mitochondrial dynamics and transfer and resulting trophoblast function. These two aims will be pursued during the final postdoctoral training period of the K99 phase. Aim 3 seeks to identify how HIV-exposed mitochondria reprogram trophoblast biology, impairing placental function and affecting fetal development in vivo. This third aim will be pursued during the R00 phase of the project. Successful completion of these aims will provide new insights into the mechanisms underlying HIV infection, identifying potential therapeutic targets to mitigate vertical transmission and placental pathologies caused by HIV and other viruses. During the mentored phase, the PI will gain expertise in primary cell culture, metabolomics, trophoblast organoids, and mitochondrial epigenetics to examine how HIV infects the placenta and disrupts cellular metabolism—establishing a foundation for the R00 phase. With guidance from the advisory team, this training and research will contribute to the identification of therapeutic strategies to improve outcomes for infants and individuals with HIV, while positioning the investigator to establish an independent, competitive R01-funded laboratory at the intersection of HIV, TNTs, placental biology, and mitochondria.", "keywords": [ "2019-nCoV", "Actins", "Advisory Committees", "Affect", "Affinity Chromatography", "Anti-viral Response", "Automobile Driving", "Biology", "Bypass", "Cell Physiology", "Cell Separation", "Cell Survival", "Cell fusion", "Cell membrane", "Cells", "Chronic", "Cloning", "Coculture Techniques", "Confocal Microscopy", "Coupled", "Cytoplasm", "Cytoskeleton", "DNA", "Data", "Deoxyadenosines", "Development", "Disproportionately impacts women", "Epigenetic Process", "F-Actin", "Fetal Development", "Fetus", "Flow Cytometry", "Foundations", "Functional disorder", "Funding", "Genes", "Genetic Transcription", "HIV", "HIV Infections", "HIV-1", "Health", "Image Cytometry", "Immune", "Immune Evasion", "Immune response", "Immunoprecipitation", "Impairment", "In Vitro", "Individual", "Infection", "Inflammation", "Investigation", "Knowledge", "Label", "Laboratories", "Link", "Mass Spectrum Analysis", "Measures", "Mediating", "Mentors", "Metabolic", "Metabolic Pathway", "Metabolic dysfunction", "Metabolism", "Microtubules", "Mitochondria", "Mitochondrial DNA", "Modeling", "Modification", "Molecular", "Mothers", "Mus", "Mutation", "Neurons", "Organoids", "Outcome", "Oxidative Phosphorylation", "Pathology", "Pathway interactions", "Patients", "Perinatal Infection", "Phase", "Placenta", "Placental Biology", "Positioning Attribute", "Pregnancy", "Pregnancy Complications", "Pregnant Women", "Primary Cell Cultures", "Process", "Proteins", "Quantitative Reverse Transcriptase PCR", "Reactive Oxygen Species", "Recombinants", "Regulation", "Research", "Research Personnel", "Risk", "Role", "Site-Directed Mutagenesis", "Study models", "System", "T-Lymphocyte", "Techniques", "Tertiary Protein Structure", "Testing", "Therapeutic", "Training", "Validation", "Vertical Transmission", "Viral", "Virion", "Virus", "Virus Diseases", "Visualization", "Western Blotting", "Work", "ZIKA", "Zika Virus", "adverse pregnancy outcome", "antiretroviral therapy", "experimental study", "fetal", "global health", "heteroplasmy", "improved outcome", "in vivo", "infant outcome", "insight", "knock-down", "live cell imaging", "metabolomics", "mitochondrial dysfunction", "mouse model", "mutant", "placental trophoblasts", "post-doctoral training", "pregnant", "programs", "protein protein interaction", "reproductive age", "single molecule real time sequencing", "single-cell RNA sequencing", "stem cells", "therapeutic target", "transmission process", "tropho" ], "approved": true } }, { "type": "Grant", "id": "15884", "attributes": { "award_id": "1F30AI179078-01A1", "title": "Understanding Ribosomal Dependent Virulence Pathways Employed by Non-Structural Protein 1 in Emerging Human Beta-Coronaviruses", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Allergy and Infectious Diseases (NIAID)" ], "program_reference_codes": [], "program_officials": [ { "id": 32891, "first_name": "MARY KATHERINE BRADFORD", "last_name": "PLIMACK", "orcid": "", "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2025-09-01", "end_date": "2028-08-31", "award_amount": 37058, "principal_investigator": { "id": 44317, "first_name": "Michael", "last_name": "Vetick", "orcid": "", "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [], "awardee_organization": { "id": 3363, "ror": "", "name": "YALE UNIVERSITY", "address": "", "city": "", "state": "CT", "zip": "", "country": "United States", "approved": true }, "abstract": "Project Summary/ Abstract Betacoronaviruses (β-CoVs) present a substantial threat to global health. Hence, determining viral targets for therapeutic intervention is an utmost priority. One attractive target is Non-structural protein 1 (Nsp1) which restricts the innate immune response by inhibiting host gene expression. Nsp1 is encoded by all β-CoVs and is hypothesized to function through three host-viral interaction pathways: two are in the cytosol requiring the ribosome, and one in the nucleus impeding host mRNA trafficking through the nuclear pore. First in the cytosol, Nsp1 restricts protein translation by binding inside the mRNA entry channel of the ribosome, sterically blocking proper host mRNA loading. Secondly, Nsp1 coordinates endonuclease cleavage of host mRNA using eukaryotic initiation factor 3g (eIF3g) as a co-factor on the ribosome. This cleaves host mRNA at the 5’ end leaving the transcripts translationally inert. However, for Middle East Respiratory Virus (MERS), I present data showing the eIF3g alone is not sufficient as a co-factor for endonuclease cleavage. Recent evidence has emerged emphasizing the importance of the two ribosome-dependent mechanisms for Nsp1 function and viral replication. However, the endonuclease function of Nsp1 remains poorly understood. I hypothesize that the endonuclease function is a crucial aspect of Nsp1 biology and elucidating its molecular mechanism will pave the way for potent drug development which can restrict current and future β-CoVs. Currently, the FDA approved drug, Montelukast, has been shown to inhibit the SARS-CoV-2 endonuclease complex. Aim 1: Determine the structure of the SARS-CoV-2 Nsp1 endonuclease complex. I present a preliminary cryoEM structure of SARS-CoV-2 Nsp1 facilitating the endonuclease complex. I show Nsp1 binding eIF3g and mRNA on 40S subunit of the ribosome, however, my study was limited in scale and is currently at low resolution (~6Å local resolution). As such I propose collecting a large dataset on a 300kV microscope to obtain a high-resolution map, resolving the molecular details of the endonuclease function. Additionally, I propose binding studies to elucidate details of the mechanism of action for Montelukast inhibiting the endonuclease complex of SARS-CoV-2 Nsp1. Successful completion of this aim will determine the molecular mechanism of the endonuclease function of Nsp1 and significantly advance Nsp1 as a therapeutic target. Aim 2: Elucidate essential co-factors for MERS Nsp1 endonuclease function. My preliminary data strongly supports that eIF3g alone is not sufficient as a co-factor for MERS Nsp1 endonuclease function. Thus, I will employ proximity labeling with TurboID to identify what co-factors are needed for MERS Nsp1 to cleave mRNA by employing biochemical and molecular biology methods. Then I will recapitulate the minimal endonuclease complex for MERS Nsp1 in-vitro. Successful completion of this aim will show how the endonuclease function of Nsp1 is conserved across the divergent landscape of β-CoVs.", "keywords": [ "2019-nCoV", "Address", "Affect", "Binding", "Biochemical", "Biological Assay", "Biology", "Cell Nucleus", "Cells", "Complex", "Cryoelectron Microscopy", "Cytosol", "Data", "Data Set", "Disease", "Disease Outbreaks", "Distant", "Drug Targeting", "Electron Microscope", "Eukaryotic Initiation Factor-1", "Eukaryotic Initiation Factors", "Evaluation", "FDA approved", "Fluorescence Anisotropy", "Foundations", "Future", "Gene Expression", "Goals", "HRX protein", "Human", "Impairment", "In Vitro", "Innate Immune Response", "Knowledge", "Label", "Maps", "Messenger RNA", "Methods", "Microscope", "Middle East Respiratory Syndrome", "Middle East Respiratory Syndrome Coronavirus", "Molecular", "Molecular Biology", "Nonstructural Protein", "Nuclear Pore", "Pathogenesis", "Pathway interactions", "Pharmaceutical Preparations", "Physicians", "Protein Engineering", "Proteins", "RNA", "Research", "Resolution", "Reverse Transcription", "Ribosomes", "Risk", "SARS-CoV-2 inhibitor", "Scientist", "Societies", "Structure", "Techniques", "Testing", "Therapeutic", "Therapeutic Intervention", "Transcript", "Transfection", "Translations", "Viral", "Virulence", "Virulence Factors", "Virus Replication", "Visualization", "Work", "betacoronavirus", "burden of illness", "cofactor", "drug development", "endonuclease", "global health", "improved", "large datasets", "mRNA Export", "montelukast", "novel", "pandemic potential", "prevent", "reconstitution", "reconstruction", "respiratory", "structural biology", "targeted treatment", "therapeutic target", "trafficking" ], "approved": true } }, { "type": "Grant", "id": "15885", "attributes": { "award_id": "1U48DP006966-01", "title": "BREATHE WELL: Development and Implementation of a Training Program to Increase Vaccination in Early Childcare and Education Centers", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Center for Immunization and Respiratory Diseases (NCIRD)" ], "program_reference_codes": [], "program_officials": [ { "id": 44318, "first_name": "NATALIE", "last_name": "DARLING", "orcid": "", "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2025-09-30", "end_date": "2029-09-29", "award_amount": 499950, "principal_investigator": { "id": 44319, "first_name": "Roshanak", "last_name": "Mehdipanah", "orcid": "", "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [ { "id": 25237, "first_name": "Marc A", "last_name": "Zimmerman", "orcid": null, "emails": "[email protected]", "private_emails": null, "keywords": "[]", "approved": true, "websites": "[]", "desired_collaboration": "", "comments": "", "affiliations": [ { "id": 770, "ror": "", "name": "UNIVERSITY OF MICHIGAN AT ANN ARBOR", "address": "", "city": "", "state": "MI", "zip": "", "country": "United States", "approved": true } ] }, { "id": 44320, "first_name": "Abram Luther", "last_name": "Wagner", "orcid": "", "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "awardee_organization": { "id": 770, "ror": "", "name": "UNIVERSITY OF MICHIGAN AT ANN ARBOR", "address": "", "city": "", "state": "MI", "zip": "", "country": "United States", "approved": true }, "abstract": "/ ABSTRACT Early childcare and education (ECE) centers are trusted institutions that engage with parents regularly, positioning them as key messengers for childhood immunization and respiratory health promotion. While ECE centers ensure compliance with mandated vaccines, their potential to support uptake of non-mandated immunizations—such as influenza vaccine, COVID-19 vaccine, maternal RSV vaccine, and nirsevimab antibody—remains underutilized. The BREATHE Well (Building Readiness, Engagement, and Trust for Healthy Environments) Toolkit is an evidence-based intervention designed to enhance ECE-originating vaccine communication, training ECE staff to effectively engage parents on immunization topics. This study will evaluate the feasibility, acceptability, and effectiveness of the BREATHE Well toolkit using a cluster- randomized controlled trial (RCT). The project will be guided by three specific aims: (1) Develop and refine the BREATHE Well toolkit through formative research, incorporating input from ECE staff, parents, and public health officials; (2) Assess the acceptability and feasibility of the toolkit through focus groups and surveys with ECE staff and parents in demonstration sites within Michigan; and (3) Evaluate the effectiveness of the toolkit in a cluster-randomized trial of ECE centers, measuring changes in parental vaccine confidence, intent to vaccinate, and staff capacity to serve as trusted messengers. The BREATHE Well toolkit will be designed as a scalable approach usable in different types of ECEs. Findings from this study will inform best practices for integrating vaccine-related education into ECE settings, with the goal of increasing parental vaccine confidence and improving uptake of recommended immunizations.", "keywords": [], "approved": true } } ], "meta": { "pagination": { "page": 1424, "pages": 1442, "count": 14420 } } }